GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bamboos Health Care Holdings 2293.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

0.42

-1.19%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in HKD, from our data supplier.

FY2026

Revenue

HK$66.7m

FY2017FY2026

Net income

HK$6.2m

FY2017FY2026

Free cash flow

—

FY2017FY2026

Shareholders' equity

HK$247.3m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueHK$66.7mHK$74.4mHK$94.8mHK$126.6mHK$140.3mHK$109.7mHK$72.3mHK$274.5mHK$302.7mHK$62.5m
Operating incomeHK$11.0mHK$22.0mHK$40.7mHK$59.9mHK$73.2mHK$73.7mHK$33.7mHK$48.2mHK$51.9mHK$40.9m
Net incomeHK$6.2mHK$17.5mHK$30.9mHK$46.9mHK$58.6mHK$61.0mHK$30.7mHK$38.9mHK$42.2mHK$32.6m
Diluted earnings per share0.020.040.080.120.150.150.080.100.110.08

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsHK$325.2mHK$315.9mHK$318.1mHK$346.8mHK$351.3mHK$240.8mHK$181.9mHK$181.0mHK$152.3mHK$124.7m
Cash and short-term investmentsHK$35.3mHK$53.0mHK$81.1mHK$93.3mHK$86.3mHK$98.3mHK$101.6mHK$118.7mHK$96.8mHK$99.3m
Total liabilitiesHK$77.9mHK$86.5mHK$99.7mHK$124.5mHK$140.7mHK$46.0mHK$28.6mHK$31.0mHK$31.7mHK$26.4m
DebtHK$58.7mHK$62.1mHK$63.7mHK$68.2mHK$69.0mHK$3.3mHK$5.8m———
Shareholders' equityHK$247.3mHK$229.4mHK$218.3mHK$222.3mHK$210.6mHK$194.8mHK$153.3mHK$150.0mHK$120.5mHK$98.3m
Shares outstanding401m402m402m400m400m400m400m400m400m400m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations—HK$36.8mHK$37.4mHK$41.9mHK$116.1mHK$49.4mHK$45.5mHK$32.0mHK$23.6mHK$34.0m
Capital spending—−HK$1.8m−HK$1.7m−HK$261,000−HK$15.7m−HK$22,000−HK$2.6m−HK$214,000−HK$878,000−HK$402,000
Free cash flow—HK$35.0mHK$35.8mHK$41.7mHK$100.4mHK$49.4mHK$42.9mHK$31.8mHK$22.7mHK$33.6m
Dividends paid—−HK$20.1m−HK$35.1m−HK$35.0m−HK$40.0m−HK$20.0m−HK$30.0m−HK$10.0m−HK$20.0m−HK$15.0m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
RevenueHK$31.5mHK$34.9mHK$34.9mHK$40.0mHK$45.9mHK$49.8mHK$59.4mHK$68.4m
Operating income−HK$201,000HK$7.1mHK$9.0mHK$13.8mHK$19.6mHK$21.1mHK$21.2mHK$39.1m
Net income−HK$3.1mHK$9.3mHK$7.4mHK$10.1mHK$13.8mHK$17.1mHK$16.3mHK$30.6m
Diluted earnings per share-0.010.020.020.030.030.040.040.08
Cash from operations—HK$6.0mHK$19.0mHK$17.0mHK$18.0m—HK$36.0mHK$5.0m
Capital spending——−HK$19.0m—————
Free cash flow——HK$0—————
Total assetsHK$325.2mHK$335.2mHK$315.9mHK$313.7mHK$318.1mHK$327.9mHK$346.8mHK$342.8m
Cash and short-term investmentsHK$35.3mHK$39.2mHK$53.0mHK$81.1mHK$81.1mHK$74.7mHK$93.3mHK$73.0m
DebtHK$58.3mHK$60.4mHK$62.5mHK$62.2mHK$63.7mHK$66.1mHK$68.2mHK$69.9m
Shareholders' equityHK$247.3mHK$254.1mHK$229.4mHK$222.7mHK$218.3mHK$223.2mHK$222.3mHK$220.7m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-19.2%-9.5%2.7%
Operating income-43.2%-31.7%-9.2%
Net income-49.0%-36.6%-13.6%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin23.3%36.8%45.8%35.2%
Net margin16.8%28.0%36.1%28.5%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings26.711.28.76.14.94.810.211.514.219.1
Price to sales2.52.62.82.32.02.74.31.62.010.0

Dividends and splits

Per share, in the currency the company pays

Paid for 11 years. Last went ex-dividend on 3 Dec 2025.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.0150.050.0880.0880.100.050.0750.025

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.